Appili Therapeutics Inc.
APLI.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 31.28% | 52.94% | -41.51% | -630.80% | 84.62% |
| Total Depreciation and Amortization | 38.10% | -16.00% | 0.00% | 0.00% | -3.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.62% | -68.54% | 545.88% | 186.27% | 379.27% |
| Change in Net Operating Assets | -212.43% | 744.34% | -80.58% | 33.54% | -57.43% |
| Cash from Operations | -205.37% | 410.78% | 71.51% | -282.00% | 205.26% |
| Capital Expenditure | 58.33% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 58.33% | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -100.00% |
| Total Debt Repaid | -3.76% | 37.85% | -69.17% | 9.96% | -41.92% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 20.25% | 13.30% | 27.97% | -46.63% | 3.78% |
| Cash from Financing | 7.94% | -112.74% | 749.08% | -13.06% | -140.46% |
| Foreign Exchange rate Adjustments | 1,200.00% | -200.00% | 142.86% | -600.00% | -133.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -228.26% | 76.57% | 140.07% | -347.60% | 263.41% |